|
Type of Parasitic
Infection |
Sex |
Treatment |
| Male |
Female |
| Age range |
Age range |
| 1-14 |
15-49 |
>49 |
1-14 |
15-49 |
>49 |
| G.lamblia |
- |
- |
1(8.33 %) |
- |
1(8.33 %) |
- |
Tindazole |
| E.histolytica |
1 (8.33 %) |
1(8.33 %) |
- |
- |
2 (16.67%) |
- |
Cotrimoxaxole, ORS |
| A.lubricoids |
1(8.33 %) |
- |
- |
- |
- |
- |
Metrindazole |
| T.saginata |
- |
- |
- |
- |
2(16.67%) |
- |
Metrindazole |
| Toxoplasmosis |
- |
1(8.33 %) |
- |
- |
- |
- |
Fansidar tablet |
| Elephantiasis |
- |
1(8.33 %) |
- |
- |
- |
- |
Doxicyclin, Albendazole |
| Malaria |
- |
1(8.33 %) |
- |
- |
- |
- |
Ciproflaxin |
| Total |
2 (16.67%) |
4 (33.33 %) |
1 (8.33%) |
- |
5 (41.67%) |
- |
|
|
